
First Patients Treated in XLRP Gene Therapy Trial
Tuesday, September 17 2024 | 14 h 31 min | Vision Science
Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked...
Read More